In response to the critical shortage of 0.9% Sodium Chloride (normal saline) injection, Baxter announced it will temporarily distribute in the US normal saline produced from its Spain manufacturing facility. The FDA has inspected the Spanish manufacturing facility to ensure the product meets FDA standards, and they will exercise discretion in the saline product’s distribution.
This Spanish import is the second overseas import of normal saline allowed by the FDA in 2014, joining Fresenius Kabi’s saline product from Norway. Additionally, FDA-approved normal saline is available from the following U.S.-based manufacturers: Baxter, B. Braun Medical, and Hospira. The shipments will not be able to fully resolve the current shortage of normal saline, but they will aid in reducing current disruptions.
Intravenous (IV) normal saline is a source of water and electrolytes which provides necessary hydration for patients unable to tolerate water or salt by mouth. IV saline also can function as a vehicle for other medications in admixture preparations.
Healthcare professionals looking to obtain this product are being urged by the FDA to contact Baxter directly.
For more information call (888) 463-6332 or visit the FDA Drug Shortage website.